News

Duke Associate Professor of Biology Steve Haase likes to compare the spread of COVID-19 to the haphazard advance of a forest fire, where tiny glowing embers, which he likens to the virus, drift in the air, among trees bringing potential harm whatever they touch.

The Duke Human Vaccine Institute Pandemic Prevention Program (DHVI-P3) has received an additional $7.6 million in federal funding to manufacture and test in humans a neutralizing monoclonal antibody for the prevention of COVID-19.

Russian President Vladimir Putin announced Tuesday that his country has developed the first-ever coronavirus vaccine, but many experts doubt its legitimacy.

The Duke EQAPOL/VQA team, led by Tom Denny in partnership with Dr. David Montefiori in the Department of Surgery, will implement a SARS-CoV-2 Neutralization Assay Concordance Survey (SNACS) in more than 50 participating laboratories worldwide.

DHVI is pleased to announce the approval of a Phase 1 clinical trial of one of our most promising antibody treatments for COVID-19.

The Duke University School of Medicine is expanding into a newly-leased research center in the Research Triangle Park (RTP). The 273,000 square foot facility in the Parmer RTP research and development campus, formerly home to pharmaceutical maker GlaxoSmithKline, is currently being renovated to accommodate School of Medicine faculty, staff and labs as soon as January 2021.

The COVID-19 pandemic has impacted laboratories across the world. Some laboratories have been labeled non-essential and face the challenges of being forcibly idled. Other laboratories have been labeled essential and face the challenge of keeping workers safe and delivering for their stakeholders during this crisis.

peculation that a vaccine for COVID-19 might be widely available by the end of this year is overly optimistic, three Duke experts said Wednesday.

Duke University’s School of Medicine research arm is building on its recent success in acquiring grants for immunology, infectious diseases and clinical trials with a move to Research Triangle Park.

The State of North Carolina enacted Session Law 2020-4, an Act to Provide Aid to North Carolinians in Response to the Coronavirus Disease 2019 Crisis, also known as the 2020 COVID-19 Recovery Act.